Teladoc Health CEO Jason Gorevic departs after stock falls 22% in February

Jason Gorevic, CEO of Teladoc Health, is stepping down after 15 years, with CFO Mala Murthy taking over as acting CEO. Gorevic’s departure follows a 22% stock drop in February. The company missed Q4 earnings estimates and projected lower-than-expected revenue for 2024. An executive search firm is assisting in finding a permanent replacement for Gorevic. Despite financial challenges, Teladoc saw revenue growth in 2023. The company faced a class action lawsuit related to its merger with Livongo. Teladoc reported a historic loss in 2022, but had a profitable 2023. The company reaffirmed its guidance for 2024.

Source link

error: Content is protected !!